Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gerber

Showing results (341-350 of 366) with videos related to

Pageof 37
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot studyG von Minckwitz, J-U Blohmer, G Raab, et al.
Environmental Science. Processes & Impacts|November 2, 2018
Understanding interactions of organic nitrates with the surface and bulk of organic films: implications for particle growth in the atmosphereA C Vander Wall, P S J Lakey, E Rossich Molina, et al.
Zentralblatt Fur Gynakologie|September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]G Von Minckwitz, K Brunnert, S D Costa, et al.
Zentralblatt Fur Gynakologie|July 23, 2005
[Systemic therapy of operable carcinoma of the breast]M Kaufmann, W Jonat, W Eiermann, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Breast (Edinburgh, Scotland)|March 2, 2019
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA studyA Mavratzas, S Baek, B Gerber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trialG von Minckwitz, H Eidtmann, S Loibl, et al.
Frontiers in Neuroinformatics|May 21, 2019
NeuroMeasure: A Software Package for Quantification of Cortical Motor Maps Using Frameless Stereotaxic Transcranial Magnetic StimulationMichael B Gerber, Alasdair C McLean, Samuel J Stephen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO studyG von Minckwitz, S Kümmel, A du Bois, et al.
Clinical Genetics|June 6, 2022
Further characterization of Borjeson-Forssman-Lehmann syndrome in females due to de novo variants in PHF6Céline B Gerber, Anna Fliedner, Oliver Bartsch, et al.
Pageof 37

Showing results (341-350 of 366) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot studyG von Minckwitz, J-U Blohmer, G Raab, et al.
Environmental Science. Processes & Impacts|November 2, 2018
Understanding interactions of organic nitrates with the surface and bulk of organic films: implications for particle growth in the atmosphereA C Vander Wall, P S J Lakey, E Rossich Molina, et al.
Zentralblatt Fur Gynakologie|September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]G Von Minckwitz, K Brunnert, S D Costa, et al.
Zentralblatt Fur Gynakologie|July 23, 2005
[Systemic therapy of operable carcinoma of the breast]M Kaufmann, W Jonat, W Eiermann, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Breast (Edinburgh, Scotland)|March 2, 2019
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA studyA Mavratzas, S Baek, B Gerber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trialG von Minckwitz, H Eidtmann, S Loibl, et al.
Frontiers in Neuroinformatics|May 21, 2019
NeuroMeasure: A Software Package for Quantification of Cortical Motor Maps Using Frameless Stereotaxic Transcranial Magnetic StimulationMichael B Gerber, Alasdair C McLean, Samuel J Stephen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO studyG von Minckwitz, S Kümmel, A du Bois, et al.
Clinical Genetics|June 6, 2022
Further characterization of Borjeson-Forssman-Lehmann syndrome in females due to de novo variants in PHF6Céline B Gerber, Anna Fliedner, Oliver Bartsch, et al.
Pageof 37